Wockhardt informs about press release

11 Dec 2023 Evaluate
Wockhardt has informed that it enclosed the Press Release titled ‘Wockhardt announces successful completion of pivotal Phase 3 pneumonia study of its macrolide antibiotic Nafithromycin WCK 4873’, which is self-explanatory.

The above information is a part of company’s filings submitted to BSE.


Wockhardt Share Price

1435.50 0.50 (0.03%)
29-Dec-2025 10:48 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.55
Dr. Reddys Lab 1265.50
Cipla 1503.95
Zydus Lifesciences 905.60
Lupin 2100.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×